Status:
UNKNOWN
Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Achalasia Cardia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Achalasia cardia is a primary oesophageal motility disorder of unknown etiology. Recently, peroral endoscopic myotomy (POEM) has gained widespread acceptance as an effective treatment modality for ach...
Detailed Description
POEM is a novel minimally invasive treatment for achalasia, which emerged as an offshoot of natural orifice transluminal endoscopic surgery (NOTES). Major adverse events during POEM are rare and there...
Eligibility Criteria
Inclusion
- All the patient(aged 18-65) who underwent POEM for achalasia cardia.
Exclusion
- Unwillingness to give written informed consent
- Patients with multiple co morbidities.
- Immunocompromised patients /on steroid therapy.
- Patients with indications for antibiotic prophylaxis (infective endocarditis).
- Patients who have received antibiotics in the last 1 week .
- Patients who have possible signs of infection during preparation for POEM
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03784365
Start Date
December 1 2018
End Date
March 1 2020
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr.Mohan Ramchandani
Hyderabad, RED ROSE Restaurant, India, 500082